Inventor
Mark A. Kay
Inventor
Los Altos, CA, US
Overview
Patents· 54 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes35%
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C12YEnzymes5%
A01KAnimal husbandry3%
C07HSugars2%
Y02ATechnologies for adaptation to climate change2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
11,091,774Non-silencing selectable marker genes and methods of use202111,015,189AAV capsid proteins for nucleic acid transfer202110,982,211tRNA derived small RNAs (tsRNAs) involved in cell viability202110,633,655tRNA derived small RNAs (tsRNAs) involved in cell viability202010,612,041Genome editing without nucleases202010,612,030Circular nucleic acid vectors, and methods for making and using the same202010,590,418Methods and compositions for RNAi mediated inhibition of gene expression in mammals202010,532,111Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies202010,517,887Methods and compositions for RNAi mediated inhibition of gene expression in mammals201910,406,244AAV vectors with expanded packaging capacity201910,385,320Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism201910,179,176Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies201910,006,047Non-silencing selectable marker genes and methods of use20189,856,469'AAV capsid proteins for nucleic acid transfer'20189,783,824'Self-complementary parvoviral vectors, and methods for making and using the same'20179,745,590'Circular nucleic acid vectors, and methods for making and using the same'20179,701,981'Nucleosome-excluding sequences (NES) as a DNA spacer in vectors results in prolonged transgene expression in eukaryotic cells'20179,428,537'tRNA derived small RNAs (tsRNAs) involved in cell viability'20169,347,073'Mini-intronic plasmid vectors'20169,255,300'Compositions and methods for modulating activity of capped small RNAS'20169,233,174'Minicircle DNA vector preparations and methods of making and using the same'20169,169,299'AAV capsid proteins for nucleic acid transfer'20159,150,882'Self-complementary parvoviral vectors, and methods for making and using the same'20159,018,179'Methods and compositions for RNAi mediated inhibition of gene expression in mammals'20158,962,331'Method of making induced pluripotent stem cell from adipose stem cells using minicircle DNA vectors'20158,945,885'Minicircle DNA vector preparations and methods of making and using the same'20158,906,387'In vivo transduction with a chimeric AAV capsid protein'20148,828,726'Circular nucleic acid vectors, and methods for making and using the same'20148,574,583'AAV capsid library and AAV capsid proteins'20138,569,573'Method of expanding human hepatocytes in vivo'20138,445,454'Use on minicircle vectors for cardiac gene therapy'20138,236,548'Minicircle DNA vector preparations and methods of making and using the same'20128,129,510'Minigene expression cassette'20128,124,407'Circular nucleic acid vectors, and methods for making and using the same'20128,067,014'Chimeric AAV capsid proteins'20118,034,922'Compositions and methods for modulating activity of capped small RNAs'20118,008,468'RNAi expression constructs with liver-specific enhancer/promoter'20117,985,739'Enhanced sleeping beauty transposon system and methods for using the same'20117,897,380'Circular nucleic acid vectors, and methods for making and using the same'20117,588,772'AAV capsid library and AAV capsid proteins'20097,351,813'Liver-specific gene expression cassettes, and methods of use'20087,060,497'Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell'20067,045,344'Adenoviral vector and methods for making and using the same'20066,943,012'Helper dependent adenoviral vector system and methods for using the same'20056,936,243'Adeno-associated viral vector-mediated delivery of DNA to cells of the liver'20056,660,905'Mice comprising engrafted functional human hepatocytes'20036,613,752'Methods of in vivo gene transfer using a sleeping beauty transposon system'20036,303,362'Adenoviral vector and methods for making and using the same'20016,132,989'Methods and compositions for enhanced stability of non-adenoviral DNA'20006,107,027'Ribozymes for treating hepatitis C'20006,107,028'Ribozymes for treating hepatitis C'20005,993,800'Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand'19995,980,886'Recombinant vectors for reconstitution of liver'19995,366,032'Rock bit'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–2020Patents assigned to KAY MARK A (12)· patent assignee history
1994Based in Dallas, TX, US· patent location history
1999–2008Patents assigned to UNIV WASHINGTON (7)· patent assignee history
1999–2005Based in Seattle, WA, US· patent location history
2001–2021Patents assigned to UNIV LELAND STANFORD JUNIOR (44)· patent assignee history
2001–2015Based in Stanford, CA, US· patent location history
2003–2021Based in Los Altos, CA, US· patent location history
2008Based in Los Altos Hills, CA, US· patent location history
2011–2015Patents assigned to KAY MARK (5)· patent assignee history
2012–2015Patents assigned to CHEN ZHI-YING (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV LELAND STANFORD JUNIOR | 44 | 2001–2021 |
| KAY MARK Aself | 12 | 1994–2020 |
| UNIV WASHINGTON | 7 | 1999–2008 |
| CHEN ZHI-YING | 6 | 2012–2015 |
| KAY MARKself | 5 | 2011–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Los Altos, California, US | 42 | 2003–2021 |
| Seattle, Washington, US | 6 | 1999–2005 |
| Stanford, California, US | 4 | 2001–2015 |
| Los Altos Hills, California, US | 1 | 2008 |
| Dallas, Texas, US | 1 | 1994 |